Parenteral and Oral Anticoagulant Treatment for Hospitalized and Post-Discharge COVID-19 Patients: A Systematic Review and Meta-Analysis

Tunjungputri, Rahajeng N; Tetrasiwi, Erpryta N; Mulansari, Nadia A; Harimurti, Kuntjoro; Nelwan, Erni J

Jurnal SINTA 1

Parenteral and Oral Anticoagulant Treatment for Hospitalized and Post-Discharge COVID-19 Patients: A Systematic Review and Meta-Analysis

ACTA MEDICA INDONESIANA · Vol. 54 No. 2 (2022)

ISSN: 2338-2732, 0125-9326
Terbit: 2022-07-07
Penerbit: The Indonesian Society of Internal Medicine
Bahasa: eng

Abstrak

Background: The use of anticoagulants has been endorsed by different hematological societies as coagulation abnormalities are key features of COVID-19 patients. This systematic review and meta-analysis aims to provide the most recent update on available evidence on the clinical benefits and risk of oral and parenteral anticoagulants, as well agents with anticoagulant properties, in hospitalized and post-discharge COVID-19 patients. Methods: This systematic review synthesizes data on the outcome of anticoagulation in hospitalized and post-discharge COVID-19 patients. Dichotomous variables from individual studies were pooled by risk ratio (RR) and their 95% confidence interval (95% CI) using the random-effects model. Meta-analyses were performed when feasible. Results: We included 32 studies from 2.815 unique citations, including 7 randomized clinical trials. A total of 33.494 patients were included. Outcomes measured include mortality and survival rates, the requirement for ICU care and mechanical ventilation. A pooled meta-analysis favors anticoagulant compared to no anticoagulant with reduced mortality in hospitalized patients (RR 0,55; 95%CI 0,43-0,66; p<0,001). Higher dose of anticoagulant also showed treatment benefit compared to standard prophylactic dose in selected populations (RR 0,68; 95%CI 0,40-0,96; p<0,001). Regular, pre-hospital anticoagulation prior to hospitalization yielded mixed result. There are currently no data on the benefit of anticoagulation on post-discharge COVID-19 patients. Conclusion: Determination of the presence of thrombosis in COVID-19 is important, as therapeutic dosage of anticoagulants, rather than prophylatic dose, would be indicated in such clinical situation. Anticoagulants were found to decrease the mortality of hospitalized COVID-19. The results from this study are important in the tailored treatment of COVID-19 patients. Further studies on the need for oral anticoagulation for outpatients or post-discharge is warranted. This study has been registered in PROSPERO database (CRD42020201418).

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 225 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

Institut Agama Islam Negeri Bone
Afiliasi tidak diketahui

Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel

Tampilkan sebagai tabel

Rekan penulis	Organisasi	Artikel bersama
Siti Setiati	Afiliasi tidak diketahui	11
Idrus Alwi	Afiliasi tidak diketahui	6
Evy Yunihastuti	Afiliasi tidak diketahui	6
Noto Dwimartutie	Afiliasi tidak diketahui	5
Rudi Putranto	Afiliasi tidak diketahui	4
Roza Mulyana	Afiliasi tidak diketahui	4
Eka Dian Safitri	Afiliasi tidak diketahui	4
Rahmi Istanti	Afiliasi tidak diketahui	4
Hamzah Shatri	Afiliasi tidak diketahui	4
Eka Ginanjar	Afiliasi tidak diketahui	3
Suzanna Immanuel	Afiliasi tidak diketahui	3
Aida Lydia	Afiliasi tidak diketahui	3
Taufik Indrajaya	Afiliasi tidak diketahui	3
Imam Subekti	Afiliasi tidak diketahui	3
Respati W Ranakusuma	Afiliasi tidak diketahui	3
Siti Rizny F Saldi	Afiliasi tidak diketahui	3
Jessica Marsigit	Afiliasi tidak diketahui	3
Suhendro Suwarto	Afiliasi tidak diketahui	3
Sri Sunarti	Afiliasi tidak diketahui	3
Rensa Rensa	Afiliasi tidak diketahui	3
Muhammad Khifzhon Azwar	Afiliasi tidak diketahui	3
Fatichati Budiningsih	Afiliasi tidak diketahui	3
Lazuardhi Dwipa	Afiliasi tidak diketahui	3
Agus Sudarso	Afiliasi tidak diketahui	3
Herdiman T Pohan	Afiliasi tidak diketahui	3
Andhika Rachman	Afiliasi tidak diketahui	2
Ika P Wijaya	Afiliasi tidak diketahui	2
Sally A Nasution	Afiliasi tidak diketahui	2
Birry Karim	Afiliasi tidak diketahui	2
Robert Sinto	Afiliasi tidak diketahui	2
Iris Rengganis	Afiliasi tidak diketahui	2
Muhammad Yamin	Institut Agama Islam Negeri Bone	2
Juferdy Kurniawan	Afiliasi tidak diketahui	2
Aru W Sudoyo	Afiliasi tidak diketahui	2
Cleopas M Rumende	Afiliasi tidak diketahui	2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.

Metadata asli (oai_dc)

<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Parenteral and Oral Anticoagulant Treatment for Hospitalized and Post-Discharge COVID-19 Patients:  A Systematic Review and Meta-Analysis</dc:title>
	<dc:creator>Tunjungputri, Rahajeng N</dc:creator>
	<dc:creator>Tetrasiwi, Erpryta N</dc:creator>
	<dc:creator>Mulansari, Nadia A</dc:creator>
	<dc:creator>Harimurti, Kuntjoro</dc:creator>
	<dc:creator>Nelwan, Erni J</dc:creator>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">anticoagulant</dc:subject>
	<dc:subject xml:lang="en-US">VTE</dc:subject>
	<dc:subject xml:lang="en-US">thromboprophylaxis</dc:subject>
	<dc:description xml:lang="en-US">Background: The use of anticoagulants has been endorsed by different hematological societies as coagulation abnormalities are key features of COVID-19 patients. This systematic review and meta-analysis aims to provide the most recent update on available evidence on the clinical benefits and risk of oral and parenteral anticoagulants, as well agents with anticoagulant properties, in hospitalized and post-discharge COVID-19 patients. Methods: This systematic review synthesizes data on the outcome of anticoagulation in hospitalized and post-discharge COVID-19 patients. Dichotomous variables from individual studies were pooled by risk ratio (RR) and their 95% confidence interval (95% CI) using the random-effects model. Meta-analyses were performed when feasible. Results: We included 32 studies from 2.815 unique citations, including 7 randomized clinical trials. A total of 33.494 patients were included. Outcomes measured include mortality and survival rates, the requirement for ICU care and mechanical ventilation. A pooled meta-analysis favors anticoagulant compared to no anticoagulant with reduced mortality in hospitalized patients (RR 0,55; 95%CI 0,43-0,66; p&amp;lt;0,001). Higher dose of anticoagulant also showed treatment benefit compared to standard prophylactic dose in selected populations (RR 0,68; 95%CI 0,40-0,96; p&amp;lt;0,001). Regular, pre-hospital anticoagulation prior to hospitalization yielded mixed result. There are currently no data on the benefit of anticoagulation on post-discharge COVID-19 patients. Conclusion: Determination of the presence of thrombosis in COVID-19 is important, as therapeutic dosage of anticoagulants, rather than prophylatic dose, would be indicated in such clinical situation. Anticoagulants were found to decrease the mortality of hospitalized COVID-19. The results from this study are important in the tailored treatment of COVID-19 patients. Further studies on the need for oral anticoagulation for outpatients or post-discharge is warranted. This study has been registered in PROSPERO database (CRD42020201418).</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2022-07-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2071</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 54 No. 2 (2022): Acta Medica Indonesiana; 190</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2071/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Rahajeng N Tunjungputri, Erpryta N Tetrasiwi, Nadia A Mulansari, Kuntjoro Harimurti, Erni J Nelwan</dc:rights>
</oai_dc:dc>